WHO WE ARE

Small charity, big ambition.

WHO WE ARE

PCR was founded in 1988 as a charity to help scientists receive funding from larger organisations. We may be small but we have come a long way since our beginnings over 30 years ago. Today, we are Prostate Cancer Research and we are funding more leading scientists than ever before, are actively finding gaps in the research system and directing our funding to plug those gaps, and are changing the way scientists and patients connect.

This year we have shown resilience in a crisis and have continued to scale up our research capacity to achieve our mission. Our worldclass scientists are dedicated to creating brand new prostate cancer treatments with the potential to reduce the side effects, dramatically cut the cost of treatment and ultimately to change the outcome.

OUR MISSION Together, we will develop and deliver breakthrough medicines and treatments.

OUR GROWTH TARGETS

2016

Income £1.36 million

2021/22

£2.7 million

2023/24

>£5.0 million

Projects 4 15 23

Scope

Extra activities

Primarily single institute Funding multiple research World centre of excellence for prostate (King’s College London) projects across the UK cancer under ‘virtual centre’ model

Open competitive grant call Funding the gaps in the prostate cancer research ecosystem

Developed our Patient Panel Patient Voice Hubs across the country

Establish US office Funding for collaboration (projected to represent 10% of expenditure)

First translational research investment